Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on allergic rhinitis.

Jeffrey C Delafuente1, Nina Han Cheigh

  • 1Geriatric Programs, Virginia Commonwealth University School of Pharmacy, Richmond, USA.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|September 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacists, nurses, and the interdisciplinary team.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2014
Same author

The silver tsunami is coming: will pharmacy be swept away with the tide?

American journal of pharmaceutical education·2009
Same author

Fall-related hospitalization and facility costs among residents of institutions providing long-term care.

The Gerontologist·2008
Same author

Pharmacokinetic and pharmacodynamic alterations in the geriatric patient.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2008
Same author

Geriatric content in pharmacotherapy and therapeutics textbooks.

American journal of pharmaceutical education·2007
Same author

Development of a competency-based assessment process for advanced pharmacy practice experiences.

American journal of pharmaceutical education·2006
Same journal

The Sky is His Wife (2001)/Jim Alford (b. 1943).

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Zada Mary cooper (1875-1961).

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Aiming for, believing in, and achieving a target a1c of less than 7.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Evaluation of OTC Product Information in Three Drug Information Databases for PDAs.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

New biotechnology approvals for 2002.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Preventing meningococcal outbreaks: an opportunity for pharmacists.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
See all related articles

Allergic rhinitis (AR) is a common inflammatory condition where the immune system overreacts to allergens. Treatment options vary and should be personalized, with new immunotherapies offering future potential.

Area of Science:

  • Immunology
  • Allergy Research
  • Inflammatory Disorders

Background:

  • Allergic rhinitis (AR) is a prevalent inflammatory condition.
  • Immune system abnormalities cause reactions to common allergens like pollen and dust mites.
  • Environmental and pharmacologic treatments are available for AR management.

Purpose of the Study:

  • To summarize current understanding and treatment of allergic rhinitis.
  • To highlight the importance of personalized treatment approaches.
  • To introduce the potential of investigational immunotherapies.

Main Methods:

  • Review of existing literature on allergic rhinitis.
  • Analysis of current therapeutic strategies.
  • Discussion of emerging immunotherapy options.

Related Experiment Videos

Main Results:

  • Allergic rhinitis involves immune system dysregulation.
  • A range of treatments exist, requiring patient-specific tailoring.
  • Investigational immunotherapies show promise for refractory cases.

Conclusions:

  • Personalized management is key for allergic rhinitis patients.
  • New immunotherapies may offer alternatives for difficult-to-treat AR.
  • Further research into immunotherapies is warranted.